Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar Turner Overton

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Journal of the International Association of Providers of AIDS Care|December 28, 2012
Efavirenz outperforms boosted atazanavir among treatment-naive HIV-1-infected persons in routine clinical careToshibumi Taniguchi, Jessica R Grubb, Diana Nurutdinova, et al.
AIDS Research and Human Retroviruses|September 1, 2011
Transmitted drug-resistant HIV type 1 remains prevalent and impacts virologic outcomes despite genotype-guided antiretroviral therapyToshibumi Taniguchi, Diana Nurutdinova, Jessica R Grubb, et al.
Vaccine|August 17, 2014
Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humansEdgar Turner Overton, Paul A Goepfert, Pamela Cunningham, et al.
Sexually Transmitted Diseases|June 16, 2022
Perceived Need and Acceptance of a Future Chlamydia Vaccine Among Health Care ProvidersAlison Footman, Nita Kanney, Linda M Niccolai, et al.
The Journal of Infectious Diseases|September 3, 2020
Hepatitis C Among High-Risk Alabamians: Disease Burden and Screening EffectivenessAnthony B Lee, Sandra Karumberia, Ashley Gilmore, et al.
Sexually Transmitted Diseases|August 10, 2022
Chlamydia Vaccination: Parent Opinions and Implications for Future Promotion ProgramsAlison Footman, Nita Kanney, Linda M Niccolai, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|October 8, 2022
Parents' Acceptance of COVID-19 Compared to Human Papillomavirus VaccinesAlison Footman, Nita Kanney, Linda M Niccolai, et al.
HIV Clinical Trials|February 27, 2016
Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: results of an exploratory substudy of METABOLIK, a phase 4, randomized trialEdgar Turner Overton, Pablo Tebas, Bruce Coate, et al.
Vaccine|February 15, 2020
A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDSEdgar Turner Overton, Steven J Lawrence, Jack T Stapleton, et al.
Sexually Transmitted Diseases|January 18, 2012
Prevalence and risk factors associated with herpes simplex virus-2 infection in a contemporary cohort of HIV-infected persons in the United StatesPragna Patel, Tim Bush, Kenneth H Mayer, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Journal of the International Association of Providers of AIDS Care|December 28, 2012
Efavirenz outperforms boosted atazanavir among treatment-naive HIV-1-infected persons in routine clinical careToshibumi Taniguchi, Jessica R Grubb, Diana Nurutdinova, et al.
AIDS Research and Human Retroviruses|September 1, 2011
Transmitted drug-resistant HIV type 1 remains prevalent and impacts virologic outcomes despite genotype-guided antiretroviral therapyToshibumi Taniguchi, Diana Nurutdinova, Jessica R Grubb, et al.
Vaccine|August 17, 2014
Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humansEdgar Turner Overton, Paul A Goepfert, Pamela Cunningham, et al.
Sexually Transmitted Diseases|June 16, 2022
Perceived Need and Acceptance of a Future Chlamydia Vaccine Among Health Care ProvidersAlison Footman, Nita Kanney, Linda M Niccolai, et al.
The Journal of Infectious Diseases|September 3, 2020
Hepatitis C Among High-Risk Alabamians: Disease Burden and Screening EffectivenessAnthony B Lee, Sandra Karumberia, Ashley Gilmore, et al.
Sexually Transmitted Diseases|August 10, 2022
Chlamydia Vaccination: Parent Opinions and Implications for Future Promotion ProgramsAlison Footman, Nita Kanney, Linda M Niccolai, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|October 8, 2022
Parents' Acceptance of COVID-19 Compared to Human Papillomavirus VaccinesAlison Footman, Nita Kanney, Linda M Niccolai, et al.
HIV Clinical Trials|February 27, 2016
Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: results of an exploratory substudy of METABOLIK, a phase 4, randomized trialEdgar Turner Overton, Pablo Tebas, Bruce Coate, et al.
Vaccine|February 15, 2020
A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDSEdgar Turner Overton, Steven J Lawrence, Jack T Stapleton, et al.
Sexually Transmitted Diseases|January 18, 2012
Prevalence and risk factors associated with herpes simplex virus-2 infection in a contemporary cohort of HIV-infected persons in the United StatesPragna Patel, Tim Bush, Kenneth H Mayer, et al.
Pageof 5